Loading...
UK Trademark — IPO
HYB-AND-SEQ
Application UK00914348593 · Removed
Quick Facts
| Application Number | UK00914348593 |
| Status | Removed |
| Owner | Bruker Spatial Biology, Inc. |
| Filed | 2015-07-08 |
| Registered | 2015-12-09 |
| Renewal Due | 2025-07-08 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
HYB-AND-SEQ has a current status of Removed.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 1 — Chemicals
Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing.
Class 5 — Pharmaceuticals
Diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes.
Class 9 — Electrical & IT
Computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices in the nature of electronic analyzers for the transport and analysis of fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type comprising laboratory equipment for screening samples, detecting the presence of analytes in samples and identifying sample types, namely, containers, dishes, microscope slides, plastic bags, swabs, test tubes, vials and wipes for collecting, storing and transmitting samples and specimens; downloadable multimedia file containing diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications relating to scientific research.
Class 10 — Medical Devices
Clinical and medical diagnostic instruments, namely, nucleic acid sequencers.
Timeline
- Filed: 2015-07-08
- Registered: 2015-12-09
- Renewal due: 2025-07-08
About This Trademark
'HYB-AND-SEQ' is a removed trademark on the UK IPO register, owned by Bruker Spatial Biology, Inc.. The application (UK00914348593) was filed on 8 July 2015 and registered on 9 December 2015. The registration is set to expire on 8 July 2025.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 9 (scientific, electrical & IT apparatus); Class 10 (medical & surgical apparatus).
The trademark is represented by Zacco UK Ltd.
Frequently Asked Questions
Who owns UK trademark UK00914348593 ('HYB-AND-SEQ')?
UK trademark UK00914348593 for the mark 'HYB-AND-SEQ' in Class 1, 5, 9, 10 is recorded on the UK IPO register as owned by Bruker Spatial Biology, Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00914348593 currently a registered trademark?
No — the UK IPO records the status of UK trademark UK00914348593 for the mark 'HYB-AND-SEQ' as removed.
Which Nice classes is UK trademark UK00914348593 registered under?
UK trademark UK00914348593 for the mark 'HYB-AND-SEQ' is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 9 (scientific, electrical & IT apparatus); Class 10 (medical & surgical apparatus). The filed specification reads: Class 1: Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diag…
When was UK trademark UK00914348593 filed?
UK trademark UK00914348593 for the mark 'HYB-AND-SEQ' was filed at the UK IPO on 8 July 2015 and registered on 9 December 2015.
When does UK trademark UK00914348593 need to be renewed?
UK trademark UK00914348593 for the mark 'HYB-AND-SEQ' is currently recorded as valid until 8 July 2025, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00914348593?
Zacco UK Ltd is listed as the attorney / representative of record for UK trademark UK00914348593 for the mark 'HYB-AND-SEQ' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "HYB-AND-SEQ" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| HYB-AND-SEQ | 86500105 | 606 | 2015-01-09 |
| HYB AND SEQ | 78642387 | 710 | 2005-06-02 |
Similar names
| Mark | Ref | Status | Filed |
|---|---|---|---|
| HYB & SEQ | 86920447 | 606 | 2016-02-25 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.